At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics; Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Viral infections
Most Recent Events
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 07 Dec 1998 New profile
- 07 Dec 1997 Preclinical development for Cancer (Unknown route)